symbol,statement_type,period_end,line_item,value
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-68393000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,68400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,End Cash Position,4472000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,4465000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,7000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,68400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,68400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,68400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,68400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,0.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,0.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,-68393000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-70792000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,-48000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-253000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-16294000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-13714000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-40483000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-400000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,0.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Deferred Tax,185000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,2146000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Depreciation,2146000.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,-151932000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-1620000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,1356000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,End Cash Position,4465000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,4729000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-264000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,1356000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,1356000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,1356000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,1356000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,0.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,0.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,-1620000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-8165000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-5835000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-11000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-111145000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-3510000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,112336000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,5254000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Deferred Tax,-415000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,2358000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Depreciation,2358000.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,-326702000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,72765000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-73851000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,End Cash Position,4525000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,5611000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-1086000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-73851000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-73851000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,-73851000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,-73851000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,0.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,0.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,72765000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,70027000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-4492000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,1319000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-30649000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,7586000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,96263000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-256000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,0.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Deferred Tax,-36000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,2719000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Depreciation,2719000.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,311000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,73104000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-72193000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,End Cash Position,5799000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,4889000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,911000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-72193000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-72193000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-72193000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,-72193000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,0.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,0.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,73104000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,45657000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-1282000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-1072000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Payable,-35440000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,14708000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,68743000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,25858000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,25858000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Deferred Tax,
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,2730000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Depreciation,2730000.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
LYPSAGEMS.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,-1141000.0
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,-319000.0
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Deferred Tax,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Depreciation,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
LYPSAGEMS.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
